Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c

Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.

For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• Largo restructures $82.2M in debt, extending maturity to 2030